Demographic and clinicoserological data of 35 SSc patients
| Range | ||
|---|---|---|
| Age (y; mean (SD)) | 48.6 (11) | 22–65 |
| M/F ratio | 3/32 | |
| Disease duration (y; mean (SD)) | 8.3 (6.0) | 1–26 |
| Raynaud’s syndrome | 97% | |
| Calcinosis | 26% | |
| Telangectasias | 86% | |
| Oesophagus | 74% | |
| Lung involvement | 88% | |
| Renal involvement | 0% | |
| Autoantibodies | ||
| ANA | 82% | |
| ACA | 40% | |
| anti-Scl70 | 37% | |
ANA = anti-nuclear; ACA = anti-centromere antibodies.